Changzhou Jiaerke Resource Chemical Science&technology Development Co., Ltd.

products: Iguratimod intermediates Iguratimod intermediates INTERMEDIATES, Anti-inflammatory analgesics and intermediatesERMEDIATES, Electronic chemicals and intermediatesTHESIS INTERMEDIATES, Tinib anti-tumor drug intermediates

Changzhou Jiaerke Resources Chemical Technology Development Co., Ltd. was founded in 2003. It is a new drug research and development company invested by Jiangsu Jiaerke Pharmaceutical Group. It is located in Zhenglu Town, Tianning District, Changzhou City, Jiangsu Province.There are five laboratories, one comprehensive analysis room, one enlarged laboratory and one pilot workshop.A number of senior research and development personnel engaged in medicine and its intermediates, including 1 doctoral degree, 3 master's degree, 12 undergraduate degree and 10 college degree.Our technological advantage: Relying on the deep cooperation of some domestic universities and American original innovative drug R & D companies associated with our company, we track their cutting-edge development information at the first time, focus on the research and production of key anti-tumor targeted drugs, and study some impurities in their key intermediates.
Country / Region
China
Province
Jiangsu
Business Type
Manufacturer
Main Products
Iguratimod intermediates Iguratimod intermediates INTERMEDIATES, Anti-inflammatory analgesics and intermediatesERMEDIATES, Electronic chemicals and intermediatesTHESIS INTERMEDIATES, Tinib anti-tumor drug intermediates
Year Established
2020
Employees
5 - 10 People
Turnover One Year
US$5 Million - US$10 Million
Main Markets
Domestic Market: 45%
Western Europe: 25%
North America: 20%

Trade Markets

Main Markets Total Revenue(%) Main Product(s)
Domestic Market 45
Western Europe 25
North America 20